Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study

Respiratory Medicine

Volumn 111, Issue , 2016, Pages 47-53

  Barrecheguren, Miriam ^a,b   Monteagudo, Mónica ^c   Ferrer, Jaume ^a,b   Borrell, Eulalia ^d   Llor, Carl ^e   Esquinas, Cristina ^a   Miravitlles, Marc ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

^d Primary Care Center Badalona 5   (Spain)

^e Primary Care Center Via Roma ^*  (Spain)

Author keywords

COPD; Epidemiology; Guidelines; Primary care; Treatment

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; PRIORITY JOURNAL; AGED; CLINICAL PRACTICE; COMBINATION DRUG THERAPY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPAIN; STATISTICS AND NUMERICAL DATA;

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGED; BRONCHODILATOR AGENTS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; GUIDELINES AS TOPIC; HUMANS; MALE; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 84959569847     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2015.12.004     Document Type: Article

References (44)

1. M. Miravitlles, J.B. Soriano, F. García-Río, L. Muñoz, E. Duran-Tauleria, G. Sanchez, and et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities Thorax 64 2009 863 868
2. J.B. Soriano, J. Ancochea, M. Miravitlles, F. García-Río, E. Duran-Tauleria, L. Muñoz, and et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007 Eur. Respir. J. 36 2010 758 765
3. D. Price, D. West, G. Brusselle, K. Gruffydd-jones, R. Jones, M. Miravitlles, and et al. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns Int. J. Chron. Obstruct. Pulmon. Dis. 2014 889 905
4. K.E. Wurst, A. Shukla, H. Muellerova, and K.J. Davis Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study COPD J. Chronic Obstr. Pulm. Dis. 11 2014 521 530
5. M. Miravitlles, J.J. Soler-Cataluña, M. Calle, J. Molina, P. Almagro, J.A. Quintano, and et al. Spanish COPD guidelines (GesEPOC). Pharmacological treatment of stable COPD Arch. Bronconeumol. 48 2012 247 257
6. M. Miravitlles, M. Calle, and J.J. Soler-Cataluña Clinical phenotypes of COPD: identification, definition and implications for guidelines Arch. Bronconeumol. 48 2012 86 98
7. J.Á. Bellón Saameño Large population data bases for primary care research: "we have the advantage" Aten. Primaria 42 2010 549 551
8. B. Bolíbar, F. Fina Avilés, R. Morros, M.D.M. Garcia-Gil, E. Hermosilla, R. Ramos, and et al. SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research Med. Clin. (Barc.) 138 2012 617 621
9. H. Müllerova, C. Chigbo, G.W. Hagan, M.A. Woodhead, M. Miravitlles, K.J. Davis, and et al. The natural history of community-acquired pneumonia in COPD patients: a population database analysis Respir. Med. 106 2012 1124 1133
10. J. Griffin, S. Lee, M. Caiado, S. Kesten, and D. Price Comparison of tiotropium bromide and combined ipratropium/salbutamol for the treatment of COPD: a UK General Practice Research Database 12-month follow-up study Prim. Care Respir. J. 17 2008 104 110
11. C. Kim, K.H. Yoo, C.K. Rhee, H.K. Yoon, Y.S. Kim, S.W. Lee, and et al. Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea Int. J. Tuberc. Lung Dis. 18 2014 737 743
12. F. Penning-van Beest, M. van Herk-Sukel, R. Gale, J.-W. Lammers, and R. Herings Three-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysis Respir. Med. 105 2011 259 265
13. M. Smidth, I. Sokolowski, L. Kærsvang, and P. Vedsted Developing an algorithm to identify people with Chronic Obstructive Pulmonary Disease (COPD) using administrative data BMC Med. Inf. Decis. Mak. 12 2012 38
14. J. Vestbo, S. Hurd, A. Agustí, P. Jones, C. Vogelmeier, A. Anzueto, and et al. Global strategy for the diagnosis, management and prevention of Chronic Obstructive Lung Disease Am. J. Respir. Crit. Care Med. 187 2013 347 365
15. B. Make, M. Dutro, J.P. Marton, D. Mapel, and R. Paulose-Ram Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients Int. J. Chron. Obstruct. Pulmon. Dis. 7 2012 1
16. T.S. Ingebrigtsen, J.L. Marott, J. Vestbo, J. Hallas, B.G. Nordestgaard, M. Dahl, and et al. Characteristics of undertreatment in COPD in the general population Chest 144 2013 1811 1818
17. M. Miravitlles, J.J. Soler-Cataluña, M. Calle, J. Molina, P. Almagro, J.A. Quintano, and et al. Spanish Guideline for COPD (GesEPOC). Update 2014 Arch. Bronconeumol. 50 Suppl 1 2014 1 16
18. J.A. Barberá, G. Peces-Barba, A.G. Agustí, J.L. Izquierdo, E. Monsó, T. Montemayor, and et al. Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica Arch. Bronconeumol. 2001 297 316
19. G. Peces-Barba, J. Albert, À. Agustí, C. Casanova, A. Casas, and J. Luis Guía clínica SEPAR-ALAT de diagnóstico y tratamiento de la EPOC Arch. Bronconeumol. 44 2008 271 281
20. R.A. Pauwels, A.S. Buist, P.M. Calverley, C.R. Jenkins, S.S. Hurd, and et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 163 2001 1256 1276
21. A.E.M. Lucas, F.W.J.M. Smeenk, I.J. Smeele, and C.P. van Schayck Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study Fam. Pract. 25 2008 86 91
22. B. Alcázar Navarrete, C. Casanova, M. Miravitlles, P. de Lucas, J.A. Riesco, and J.M. Rodríguez González-Moro Correct use of inhaled corticosteroids in chronic obstructive pulmonary disease: a consensus document Arch. Bronconeumol. 51 2015 193 198
23. M. Raluy-Callado, D. Lambrelli, S. MacLachlan, and J.M. Khalid Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013 Int. J. Chron. Obstruct. Pulmon. Dis. 10 2015 925 937
24. K.J. Davis, S.H. Landis, Y.-M. Oh, D.M. Mannino, M.K. Han, T. van der Molen, and et al. Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries Int. J. Chron. Obstruct. Pulmon. Dis. 10 2015 39 55
25. G. Salinas, C. Williamson, R. Kalhan, B. Thomashow, J. Scheckermann, J.W. Walsh, and et al. Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians Int. J. Chron. Obstruct. Pulmon. Dis. 6 2011 171
26. C.M. Sanguinetti, F. De Benedetto, C.F. Donner, S. Nardini, and A. Visconti Pneumocafé project: an inquiry on current COPD diagnosis and management among General Practitioners in Italy through a novel tool for professional education Multidiscip. Respir. Med. 9 2014 35
27. M. Miravitlles, A. Sicras, C. Crespo, M. Cuesta, M. Brosa, J. Galera, and et al. Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting Ther. Adv. Respir. Dis. 7 2013 139 150
28. N. Roche, H. Reddel, R. Martin, G. Brusselle, A. Papi, M. Thomas, and et al. Quality standards for real-world research Ann. Am. Thorac. Soc. 11 2 2014 S99 S104
29. I. Vinagre, M. Mata-Cases, E. Hermosilla, R. Morros, F. Fina, M. Rosell, and et al. Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain) Diabetes Care 35 2012 774 779
30. L. Bilde, A. Rud Svenning, J. Dollerup, H. Baekke Borgeskov, and P. Lange The cost of treating patients with COPD in Denmark - a population study of COPD patients compared with non-COPD controls Respir. Med. 101 2007 539 546
31. D.P. Miller, S.E. Watkins, T. Sampson, and K.J. Davis Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of cataracts and glaucoma among chronic obstructive pulmonary disease patients in the UK General Practice Research Database Int. J. Chron. Obstruct. Pulmon. Dis. 6 2011 467 476
32. M. Cazzola, E. Puxeddu, G. Bettoncelli, L. Novelli, A. Segreti, C. Cricelli, and et al. The prevalence of asthma and COPD in Italy: a practice-based study Respir. Med. 105 2011 386 391
33. F. De Vries, T.P. van Staa, M.S.G.M. Bracke, C. Cooper, H.G.M. Leufkens, and J.-W.J. Lammers Severity of obstructive airway disease and risk of osteoporotic fracture Eur. Respir. J. 25 2005 879 884
34. A.S. Gershon, C. Wang, J. Guan, J. Vasilevska-Ristovska, L. Cicutto, and T. To Identifying individuals with physcian diagnosed COPD in health administrative databases COPD 6 2009 388 394
35. G.D.R. James, I. Petersen, I. Nazareth, J.A. Wedzicha, and G.C. Donaldson Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study Prim. Care Respir. J. 22 2013 271 277
36. C. Schneider, S.S. Jick, U. Bothner, and C.R. Meier COPD and the risk of depression Chest 137 2010 341 347
37. J.B. Soriano, W.C. Maier, G. Visick, and N.B. Pride Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database Eur. J. Epidemiol. 17 2001 1075 1080
38. J.K. Quint, H. Mullerova, R.L. DiSantostefano, H. Forbes, S. Eaton, J.R. Hurst, and et al. Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD) BMJ Open 4 2014 e005540-e005540
39. M. Monteagudo, T. Rodriguez-Blanco, J. Parcet, N. Peñalver, C. Rubio, M. Ferrer, and et al. Variability in the performing of spirometry and its consequences in the treatment of COPD in primary care Arch. Bronconeumol. 47 2011 226 233
40. H. Melbye, E. Drivenes, L.G. Dalbak, T. Leinan, S. Hoegh-Henrichsen, and A. Ostrem Asthma, chronic obstructive pulmonary disease or both? Diagnostic labeling spirometry in primary care patients aged 40 years or more Int. J. Chron. Obstruct. Pulmon. Dis. 6 2011 597 603
41. M. Arne, K. Lisspers, B. Ställberg, G. Boman, H. Hedenström, C. Janson, and et al. How often is diagnosis of COPD confirmed with spirometry? Respir. Med. 104 2010 550 556
42. P.P. Walker, P. Mitchell, F. Diamantea, C.J. Warburton, and L. Davies Effect of primary-care spirometry on the diagnosis and management of COPD Eur. Respir. J. 28 2006 945 952
43. M. Barrecheguren, C. Esquinas, and M. Miravitlles The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges Curr. Opin. Pulm. Med. 21 2015 74 79
44. M. Miravitlles, M. Barrecheguren, and M. Román-Rodríguez Frequency and characteristics of different clinical phenotypes of COPD Int. J. Tuberc. Lung Dis. 19 2015 992 998